Thus, an increased level of IL1B expression has been observed in CCC patients, which has led to propose the different activation pathways of this cytokine as a therapeutic target to prevent the evolution of cardiomyopathy, fibrosis and inflammation in Chagas disease [62]. The gene discussed is IL1B; the disease is cardiomyopathy.